SHELBY MOUGEOT: Open Payments
NPI 1457081549 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,299 in 82 payments from 16 companies in 2025. Trend: 2023 $1,137 · 2024 $1,182 · 2025 $1,299
Food & beverage: $1,299
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $206 |
| Novo Nordisk Inc | 13 | $184 |
| Lundbeck LLC | 13 | $178 |
| Amgen Inc. | 14 | $144 |
| Lilly USA, LLC | 5 | $96 |
| Sumitomo Pharma America, Inc. | 4 | $82 |
| TOLMAR, INC. | 4 | $75 |
| GlaxoSmithKline, LLC. | 4 | $70 |
| Exact Sciences Corporation | 3 | $57 |
| AstraZeneca Pharmaceuticals LP | 3 | $50 |
Products named: UBRELVY, REXULTI, VYEPTI, OTEZLA, GEMTESA, MOUNJARO, JATENZO, Rybelsus.
Industry payments across LA — which companies pay providers there.
